KALA BIO INC (KALA) Fundamental Analysis & Valuation

NASDAQ:KALA • US4831192020

Current stock price

0.2368 USD
-0.01 (-3.7%)
At close:
0.237 USD
+0 (+0.08%)
After Hours:

This KALA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KALA Profitability Analysis

1.1 Basic Checks

  • In the past year KALA has reported negative net income.
  • In the past year KALA has reported a negative cash flow from operations.
  • KALA had negative earnings in each of the past 5 years.
  • In the past 5 years KALA always reported negative operating cash flow.
KALA Yearly Net Income VS EBIT VS OCF VS FCFKALA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • The Return On Assets of KALA (-74.28%) is worse than 65.26% of its industry peers.
  • The Return On Equity of KALA (-627.91%) is worse than 78.50% of its industry peers.
Industry RankSector Rank
ROA -74.28%
ROE -627.91%
ROIC N/A
ROA(3y)-65.78%
ROA(5y)-69.35%
ROE(3y)-371.5%
ROE(5y)-413.54%
ROIC(3y)N/A
ROIC(5y)N/A
KALA Yearly ROA, ROE, ROICKALA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KALA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KALA Yearly Profit, Operating, Gross MarginsKALA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. KALA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, KALA has more shares outstanding
  • The number of shares outstanding for KALA has been increased compared to 5 years ago.
  • Compared to 1 year ago, KALA has an improved debt to assets ratio.
KALA Yearly Shares OutstandingKALA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
KALA Yearly Total Debt VS Total AssetsKALA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • KALA has an Altman-Z score of -18.56. This is a bad value and indicates that KALA is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of KALA (-18.56) is worse than 82.53% of its industry peers.
  • KALA has a Debt/Equity ratio of 2.65. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.65, KALA is not doing good in the industry: 79.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Altman-Z -18.56
ROIC/WACCN/A
WACCN/A
KALA Yearly LT Debt VS Equity VS FCFKALA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

  • KALA has a Current Ratio of 1.99. This is a normal value and indicates that KALA is financially healthy and should not expect problems in meeting its short term obligations.
  • KALA has a Current ratio of 1.99. This is in the lower half of the industry: KALA underperforms 77.16% of its industry peers.
  • KALA has a Quick Ratio of 1.99. This is a normal value and indicates that KALA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.99, KALA is doing worse than 75.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
KALA Yearly Current Assets VS Current LiabilitesKALA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. KALA Growth Analysis

3.1 Past

  • KALA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.09%, which is quite impressive.
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • KALA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.21% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y49.59%
EPS Next 2Y38.5%
EPS Next 3Y25.21%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KALA Yearly Revenue VS EstimatesKALA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2021 2022 2031 2032 50M 100M 150M
KALA Yearly EPS VS EstimatesKALA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. KALA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KALA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KALA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KALA Price Earnings VS Forward Price EarningsKALA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KALA Per share dataKALA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as KALA's earnings are expected to grow with 25.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y25.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KALA Dividend Analysis

5.1 Amount

  • No dividends for KALA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KALA Fundamentals: All Metrics, Ratios and Statistics

KALA BIO INC

NASDAQ:KALA (3/20/2026, 8:04:59 PM)

After market: 0.237 +0 (+0.08%)

0.2368

-0.01 (-3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-19
Earnings (Next)03-30
Inst Owners0.77%
Inst Owner Change38.69%
Ins Owners0.01%
Ins Owner Change-6.25%
Market Cap215.80M
Revenue(TTM)N/A
Net Income(TTM)-35.84M
Analysts45.71
Price Target1.53 (546.11%)
Short Float %0.11%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)1.58%
Max EPS beat(2)41.67%
EPS beat(4)4
Avg EPS beat(4)25.08%
Min EPS beat(4)1.58%
Max EPS beat(4)41.67%
EPS beat(8)7
Avg EPS beat(8)15.48%
EPS beat(12)7
Avg EPS beat(12)-2.76%
EPS beat(16)9
Avg EPS beat(16)-6.88%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-63.82%
EPS NQ rev (3m)-63.82%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 37.81
P/tB 37.81
EV/EBITDA N/A
EPS(TTM)-5.72
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -74.28%
ROE -627.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.78%
ROA(5y)-69.35%
ROE(3y)-371.5%
ROE(5y)-413.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z -18.56
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)113.01%
Cap/Depr(5y)128.61%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.44%
EPS Next Y49.59%
EPS Next 2Y38.5%
EPS Next 3Y25.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.7%
OCF growth 3YN/A
OCF growth 5YN/A

KALA BIO INC / KALA Fundamental Analysis FAQ

What is the fundamental rating for KALA stock?

ChartMill assigns a fundamental rating of 1 / 10 to KALA.


What is the valuation status of KALA BIO INC (KALA) stock?

ChartMill assigns a valuation rating of 1 / 10 to KALA BIO INC (KALA). This can be considered as Overvalued.


How profitable is KALA BIO INC (KALA) stock?

KALA BIO INC (KALA) has a profitability rating of 0 / 10.


How financially healthy is KALA BIO INC?

The financial health rating of KALA BIO INC (KALA) is 1 / 10.